BusinessSorrento Therapeutics CEO Dr. Henry Ji Invited to the Fourth International Vatican Conference on “Unite to Cure”By Nasdaq OMXApr 23, 2018, 12:01 PM UTC
BusinessSorrento Therapeutics Chairman/CEO update to stockholdersBy Nasdaq OMXMar 28, 2018, 11:28 PM UTC
BusinessSorrento Therapeutics Announces Unsecured $120.5M Convertible Note FinancingBy Nasdaq OMXMar 27, 2018, 12:02 PM UTC
BusinessSorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018By Nasdaq OMXMar 19, 2018, 12:00 PM UTC
